The National Allergy Strategy is an initiative of ASCIA and A&AA
Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades. This has contributed to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers. Currently affecting more than 4 million Australians, the rapid and continuing rise of allergic diseases is therefore a serious public health issue that requires action by all levels of government and the community.
To address these issues, the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. An important guiding principle is to be patient and consumer focused, and this is reflected in the Mission of the National Allergy Strategy:
To improve the health and quality of life of Australians with allergic diseases, and minimise the burden of allergic diseases on individuals, their carers, healthcare services and the community.
A&AA is the leading national patient organisation for allergy in Australia
Allergy & Anaphylaxis Australia (A&AA) is a charitable, not-for-profit organisation established in 1993. As the trusted charity for allergy support, their mission is to listen, guide and educate Australians living with allergic disease.
To improve awareness of allergy in the Australian community, they share current information, educate, advocate, promote research, guide and support Australians to manage life with allergy.
Their outreach extends to individuals, families, schools, workplaces, health professionals, government, food industry and all Australians. Living with one or more allergic conditions can impact on your quality of life. Talk to them if you need to know more or need to be pointed in the right direction. With more than 25 years experience and a Medical Advisory Board to consult for advice, they will do their best to assist you in a world where research into allergic disease continues.
ASCIA is the peak medical body for allergy and clinical immunology in Australasia
The Australasian Society of Clinical Immunology and Allergy (ASCIA) was established in 1990 as the peak professional body of clinical immunology and allergy in Australia and New Zealand.
In 2015 ASCIA and A&AA developed the first National Allergy Strategy for Australia, in conjunction with other key stakeholders. Implementation of the National Allergy Strategy commenced in 2016-2017.
ASCIA's mission is to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with immune system disorders. These include allergic diseases, immunodeficiencies and other immune diseases.